Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts-Reference-Cited by-同舟云学术

Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts

Published:2022-09-04 Issue:12 Volume:96 Page:3315-3329
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Umbaugh David S.^ORCID,Soder Rupal P.,Nguyen Nga T.,Adelusi Olamide,Robarts Dakota R.,Woolbright Ben,Duan Luqi,Abhyankar Sunil,Dawn Buddhadeb,Apte Udayan,Jaeschke Hartmut^ORCID,Ramachandran Anup^ORCID

Funder

Midwest Stem Cell Center

Midwest Biomedical Accelerator Consortium, an NIH Research Evaluation and Commercialization Hub

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of General Medicine Liver Disease COBRE

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00204-022-03372-5.pdf

Reference57 articles.

1. Akakpo JY, Ramachandran A, Curry SC, Rumack BH, Jaeschke H (2022) Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose. Arch Toxicol 96(2):453–465

2. Akakpo JY, Ramachandran A, Kandel SE, Ni HM, Kumer SC, Rumack BH, Jaeschke H (2018) 4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes. Hum Exp Toxicol 37(12):1310–1322

3. Ankrum JA, Ong JF, Karp JM (2014) Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32(3):252–260

4. Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, Bateman DN, Goldring CE, Park BK (2013) Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 58(2):777–787

5. Arnold K, Xu Y, Sparkenbaugh EM, Li M, Han X, Zhang X, Xia K, Piegore M, Zhang F, Zhang X, Henderson M, Pagadala V, Su G, Tan L, Park PW, Stravitz RT, Key NS, Linhardt RJ, Pawlinski R, Xu D, Liu J (2020) Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure. Sci Transl Med 12(535):eaav8075

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of ferroptosis inhibitors in a murine model of acetaminophen‐induced liver injury;Journal of Biochemical and Molecular Toxicology;2024-07-31

2. Clinically relevant therapeutic approaches against acetaminophen hepatotoxicity and acute liver failure;Biochemical Pharmacology;2024-02

3. Biomarker discovery in acetaminophen hepatotoxicity: leveraging single-cell transcriptomics and mechanistic insight;Expert Review of Clinical Pharmacology;2024-01-22

4. The essential role of O-GlcNAcylation in hepatic differentiation;Hepatology Communications;2023-11

5. Nrf2 as a therapeutic target in acetaminophen hepatotoxicity: A case study with sulforaphane;Journal of Biochemical and Molecular Toxicology;2023-08-20